ArticlePharmaceuticals (Basel, Switzerland)2021

Did the Introduction of Biosimilars Influence Their Prices and Utilization? The Case of Biologic Disease Modifying Antirheumatic Drugs (bDMARD) in Bulgaria.

Konstantin Tachkov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.